Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 2/20 | 0.47 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.47 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.45 |
| ▸ | PNLIP | P16233 | 8/20 | 0.41 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.39 |
| ▸ | IGF1R | P08069 | 1/20 | 0.39 |
| ▸ | GAK | O14976 | 1/20 | 0.39 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | KDR | P35968 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2955700 | 0.80 | IGF1R (0.45) | SCN9ASCN5AMAPTIGF1RGAK | |
| SCHEMBL2968878 | 0.79 | IGF1R (0.47) | MAPTIGF1RSMN1; SMN2KDR | |
| SCHEMBL2968548 | 0.79 | IGF1R (0.42) | SCN9ASCN5AMAPTIGF1RGAK | |
| SCHEMBL2955707 | 0.78 | IGF1R (0.41) | SCN9ASCN5AP2RX3MAPTIGF1R | |
| SCHEMBL2970983 | 0.78 | NR4A2 (0.42) | SCN9ASCN5AP2RX3MAPTIGF1R | |
| SCHEMBL2957627 | 0.77 | IGF1R (0.40) | SCN9ASCN5AMAPTIGF1RGAK | |
| SCHEMBL2968819 | 0.75 | IGF1R (0.45) | SCN9AMAPTIGF1RSMN1; SMN2NPC1 | |
| SCHEMBL2961143 | 0.75 | IGF1R (0.40) | SCN9ASCN5AMAPTNPSR1IGF1R | |
| SCHEMBL8328406 | 0.73 | PDE10A (0.46) | P2RX3MAPTNPSR1IGF1R | |
| SCHEMBL2964444 | 0.73 | RIPK2 (0.39) | MAPTIGF1RTP53KDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024057740-A1 | TREATMENT AGENT FOR ACRYLIC FIBERS AND USE OF SAME | 松本油脂製薬株式会社 | 2024-03-21 | — | — | WO | disclosed |
| CN-107994269-B | Lead-carbon battery with high cycle times and preparation method thereof | 江苏华富储能新技术股份有限公司 | 2024-01-30 | — | — | CN | disclosed |
| US-20230375291-A1 | CIRCULATING COOLING WATER TREATMENT METHOD AND COOLING PERFORMANCE IMPROVEMENT METHOD | KURITA WATER INDUSTRIES LTD. (JP) | 2023-11-23 | — | — | US | disclosed |
| EP-4230949-A1 | CIRCULATING COOLING WATER TREATMENT METHOD AND COOLING PERFORMANCE IMPROVEMENT METHOD | Kurita Water Industries Ltd. (JP) | 2023-08-23 | — | — | EP | disclosed |
| CN-116478494-A | Sealing composition, method for producing same, and sealing sheet | 味之素株式会社 | 2023-07-25 | — | — | CN | disclosed |
| CN-116194623-A | Method for cleaning aluminum nitride single crystal substrate, method for producing aluminum nitride single crystal laminate, method for producing aluminum nitride single crystal substrate, and aluminum nitride single crystal substrate | 株式会社德山 | 2023-05-30 | — | — | CN | disclosed |
| US-20210310187-A1 | ARTIFICIAL LEATHER FOR AUTOMOTIVE INTERIOR MATERIALS AND METHOD OF MANUFACTURING THE SAME | LG HAUSYS, LTD. (KR) | 2021-10-07 | — | — | US | disclosed |
| CN-110541228-B | Moisture-absorbing dry textile fabric | 江苏大毛牛新材料有限公司 | 2021-08-10 | — | — | CN | disclosed |
| US-20210222361-A1 | ARTIFICIAL LEATHER FOR AUTOMOTIVE INTERIOR MATERIALS AND METHOD OF MANUFACTURING THE SAME | LG HAUSYS, LTD. (KR) | 2021-07-22 | — | — | US | disclosed |
| CN-107994230-B | Lithium iron phosphate cathode material and preparation method thereof | 华富(江苏)锂电新技术有限公司 | 2021-02-26 | — | — | CN | disclosed |
| US-7763731-B2 | Anti-viral compounds | ABBOTT LABORATORIES (US) | 2010-07-27 | — | — | US | disclosed |
| EP-1979349-A2 | ANTI-VIRAL COMPOUNDS | Abbott Laboratories (US) | 2008-10-15 | — | — | EP | disclosed |
| EP-1013258-B1 | Amphipatic lipid dispersion | KAO CORP (JP) | 2008-08-20 | — | — | EP | disclosed |
| EP-1093800-B1 | Cosmetic composition | KAO CORP (JP) | 2007-12-19 | — | — | EP | disclosed |
| US-20070232645-A1 | ANTI-VIRAL COMPOUNDS | ABBVIE INC. | 2007-10-04 | — | — | US | disclosed |
| WO-2007076035-A2 | ANTI-VIRAL COMPOUNDS | ABBOTT LABORATORIES (US) | 2007-07-05 | — | — | WO | disclosed |
| US-6830754-B2 | Amphipatic lipid containing a hydroxy and amide group; and of a surfactant in an aqueous medium; a washing-away type cosmetic composition comprising the dispersion | KAO CORPORATION (JP) | 2004-12-14 | — | — | US | disclosed |
| US-20020058052-A1 | AMPHIPATIC LIPID DISPERSION | KAO CORPORATION (JP) | 2002-05-16 | — | — | US | disclosed |
| EP-1093800-A2 | Cosmetic composition | Kao Corporation (JP) | 2001-04-25 | — | — | EP | disclosed |
| EP-1013258-A2 | Amphipatic lipid dispersion | Kao Corporation (JP) | 2000-06-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070232645-A1 | ANTI-VIRAL COMPOUNDS | HAVCR2, MAVS, EIF2AK2 | SCN9A 3852/4885SCN5A 4400/4885GRM4 4383/4885 |
| US-20020058052-A1 | AMPHIPATIC LIPID DISPERSION | LIPA, MGLL, CUTA | SCN9A 2743/4885SCN5A 1424/4885GRM4 3970/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.